Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-16-664653
Filing Date
2016-07-29
Accepted
2016-07-29 16:31:24
Documents
6
Effectiveness Date
2016-07-29

Document Format Files

Seq Description Document Type Size
1 S-8 d164308ds8.htm S-8 68593
2 EX-5.1 d164308dex51.htm EX-5.1 13808
3 EX-10.1 d164308dex101.htm EX-10.1 116245
4 EX-23.1 d164308dex231.htm EX-23.1 1664
5 GRAPHIC g164308g29y49.jpg GRAPHIC 2348
6 GRAPHIC g164308g37e46.jpg GRAPHIC 1650
  Complete submission text file 0001193125-16-664653.txt   207135
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-212775 | Film No.: 161794463
SIC: 2834 Pharmaceutical Preparations